{"transactions":[{"id":1683129,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2024-01-09T23:00:29.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":false,"shares":1634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1634},"source":{"system":"sec-edgar","filing":"0001209191-24-001267","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001267/doc4.xml","form_type":"4"}},{"id":1683128,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:29.000Z","date":"2024-01-08","kind":"sale","planned":false,"acquired":false,"shares":590,"price":29.96,"value":17676.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.6641 to $29.96, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":46901,"source":{"system":"sec-edgar","filing":"0001209191-24-001267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001267/doc4.xml","form_type":"4"}},{"id":1683127,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2024-01-09T23:00:29.000Z","date":"2024-01-06","kind":"exercise","planned":false,"acquired":true,"shares":1634,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":47491,"source":{"system":"sec-edgar","filing":"0001209191-24-001267","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919124001267/doc4.xml","form_type":"4"}},{"id":1763905,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-10-07T02:00:00.000Z","date":"2023-10-05","kind":"exercise","planned":false,"acquired":false,"shares":36174,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":60289,"derivative":{"underlying":"Common Stock","underlying_shares":36174},"source":{"system":"sec-edgar","filing":"0001209191-23-052390","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052390/doc4.xml","form_type":"4"}},{"id":1763904,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-10-07T02:00:00.000Z","date":"2023-10-06","kind":"sale","planned":false,"acquired":false,"shares":16369,"price":21.96,"value":359463.24,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":45857,"source":{"system":"sec-edgar","filing":"0001209191-23-052390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052390/doc4.xml","form_type":"4"}},{"id":1763903,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-10-07T02:00:00.000Z","date":"2023-10-05","kind":"exercise","planned":false,"acquired":true,"shares":36174,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 539 shares acquired by the Reporting Person under the Issuer's 2004 Employee Stock Purchase Plan on May 15, 2023."}],"balance_after":62226,"source":{"system":"sec-edgar","filing":"0001209191-23-052390","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123052390/doc4.xml","form_type":"4"}},{"id":1906751,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-05-04T01:14:07.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":18172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning May 1, 2024."}],"balance_after":18172,"derivative":{"underlying":"Common Stock","underlying_shares":18172},"source":{"system":"sec-edgar","filing":"0001209191-23-027204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027204/doc4.xml","form_type":"4"}},{"id":1906750,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2023-05-04T01:14:07.000Z","date":"2023-05-01","kind":"grant","planned":false,"acquired":true,"shares":59957,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on May 1, 2024. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":59957,"derivative":{"exercise_price":21.75,"expiration_date":"2033-05-01","underlying":"Common Stock","underlying_shares":59957},"source":{"system":"sec-edgar","filing":"0001209191-23-027204","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123027204/doc4.xml","form_type":"4"}},{"id":1909010,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-05-02T23:06:34.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-23-026746","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026746/doc4.xml","form_type":"4"}},{"id":1909009,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-05-02T23:06:34.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":917,"price":21.18,"value":19422.06,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":25513,"source":{"system":"sec-edgar","filing":"0001209191-23-026746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026746/doc4.xml","form_type":"4"}},{"id":1909008,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-05-02T23:06:34.000Z","date":"2023-04-29","kind":"exercise","planned":false,"acquired":true,"shares":3005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":26430,"source":{"system":"sec-edgar","filing":"0001209191-23-026746","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123026746/doc4.xml","form_type":"4"}},{"id":1923187,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-04-08T00:32:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":false,"shares":4773,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":14319,"derivative":{"underlying":"Common Stock","underlying_shares":4773},"source":{"system":"sec-edgar","filing":"0001209191-23-023861","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023861/doc4.xml","form_type":"4"}},{"id":1923186,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-04-08T00:32:09.000Z","date":"2023-04-06","kind":"sale","planned":false,"acquired":false,"shares":1456,"price":18.16,"value":26440.96,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.16 to $18.20, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":23425,"source":{"system":"sec-edgar","filing":"0001209191-23-023861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023861/doc4.xml","form_type":"4"}},{"id":1923185,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-04-08T00:32:09.000Z","date":"2023-04-05","kind":"exercise","planned":false,"acquired":true,"shares":4773,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Issuer's common stock."}],"balance_after":24881,"source":{"system":"sec-edgar","filing":"0001209191-23-023861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123023861/doc4.xml","form_type":"4"}},{"id":1991069,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-02-28T02:00:26.000Z","date":"2023-02-23","kind":"exercise","acquired":false,"shares":2214,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23, 2022."}],"balance_after":4428,"derivative":{"underlying":"Common Stock","underlying_shares":2214},"source":{"system":"sec-edgar","filing":"0001209191-23-013469","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013469/doc4.xml","form_type":"4"}},{"id":1991068,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:26.000Z","date":"2023-02-24","kind":"sale","acquired":false,"shares":803,"price":18.78,"value":15080.34,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":20108,"source":{"system":"sec-edgar","filing":"0001209191-23-013469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013469/doc4.xml","form_type":"4"}},{"id":1991067,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-02-28T02:00:26.000Z","date":"2023-02-23","kind":"exercise","acquired":true,"shares":2214,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":20911,"source":{"system":"sec-edgar","filing":"0001209191-23-013469","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123013469/doc4.xml","form_type":"4"}},{"id":2057911,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2023-01-11T01:20:10.000Z","date":"2023-01-06","kind":"exercise","acquired":false,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":1634,"derivative":{"underlying":"Common Stock","underlying_shares":1633},"source":{"system":"sec-edgar","filing":"0001209191-23-002894","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002894/doc4.xml","form_type":"4"}},{"id":2057910,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-01-11T01:20:10.000Z","date":"2023-01-09","kind":"sale","acquired":false,"shares":589,"price":17.1303,"value":10089.7467,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.13 to $17.19, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":18697,"source":{"system":"sec-edgar","filing":"0001209191-23-002894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002894/doc4.xml","form_type":"4"}},{"id":2057909,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2023-01-11T01:20:10.000Z","date":"2023-01-06","kind":"exercise","acquired":true,"shares":1633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 911 shares of the Issuer's common stock acquired by the reporting person on May 16, 2022 pursuant to an employee stock purchase program."}],"balance_after":19286,"source":{"system":"sec-edgar","filing":"0001209191-23-002894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919123002894/doc4.xml","form_type":"4"}},{"id":2284984,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-05-04T00:51:01.000Z","date":"2022-04-29","kind":"exercise","acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":3005,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-22-026938","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026938/doc4.xml","form_type":"4"}},{"id":2284983,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2022-05-04T00:51:01.000Z","date":"2022-05-02","kind":"sale","acquired":false,"shares":894,"price":18.182,"value":16254.708,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.18 to $18.425, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon\nrequest, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":16742,"source":{"system":"sec-edgar","filing":"0001209191-22-026938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026938/doc4.xml","form_type":"4"}},{"id":2284982,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Common Stock","published_at":"2022-05-04T00:51:01.000Z","date":"2022-04-29","kind":"exercise","acquired":true,"shares":3005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Acadia common stock."}],"balance_after":17636,"source":{"system":"sec-edgar","filing":"0001209191-22-026938","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122026938/doc4.xml","form_type":"4"}},{"id":2301759,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:47:05.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":96463,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Subject to accelerated vesting in certain circumstances, the restricted stock units vest as follows: 37.5% of the shares vest 18 months from the grant date; 12.5% of the shares vest on the second anniversary of the grant date; and 25% of the shares vest on each of the third and fourth anniversaries of the grant date."}],"balance_after":96463,"derivative":{"underlying":"Common Stock","underlying_shares":96463},"source":{"system":"sec-edgar","filing":"0001209191-22-023740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023740/doc4.xml","form_type":"4"}},{"id":2301758,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Restricted Stock Units","published_at":"2022-04-07T22:47:05.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":19092,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 5, 2023."}],"balance_after":19092,"derivative":{"underlying":"Common Stock","underlying_shares":19092},"source":{"system":"sec-edgar","filing":"0001209191-22-023740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023740/doc4.xml","form_type":"4"}},{"id":2301757,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP,General Counsel, Secretary"}}],"security":"Stock Options (Right to Buy)","published_at":"2022-04-07T22:47:05.000Z","date":"2022-04-05","kind":"grant","acquired":true,"shares":65517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 5, 2023. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":65517,"derivative":{"exercise_price":25.75,"expiration_date":"2032-04-05","underlying":"Common Stock","underlying_shares":65517},"source":{"system":"sec-edgar","filing":"0001209191-22-023740","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122023740/doc4.xml","form_type":"4"}},{"id":2372883,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-02-25T22:42:53.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":2213,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":6642,"derivative":{"underlying":"Common Stock","underlying_shares":2213},"source":{"system":"sec-edgar","filing":"0001209191-22-013277","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013277/doc4.xml","form_type":"4"}},{"id":2372882,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-25T22:42:53.000Z","date":"2022-02-23","kind":"sale","acquired":false,"shares":782,"price":23.8,"value":18611.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":14631,"source":{"system":"sec-edgar","filing":"0001209191-22-013277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013277/doc4.xml","form_type":"4"}},{"id":2372881,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-02-25T22:42:53.000Z","date":"2022-02-23","kind":"exercise","acquired":true,"shares":2213,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":15413,"source":{"system":"sec-edgar","filing":"0001209191-22-013277","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122013277/doc4.xml","form_type":"4"}},{"id":2439237,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2022-01-10T23:24:45.000Z","date":"2022-01-06","kind":"exercise","acquired":false,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":3267,"derivative":{"underlying":"Common Stock","underlying_shares":1633},"source":{"system":"sec-edgar","filing":"0001209191-22-002750","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002750/doc4.xml","form_type":"4"}},{"id":2439236,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-01-10T23:24:45.000Z","date":"2022-01-06","kind":"sale","acquired":false,"shares":574,"price":23.05,"value":13230.7,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":13200,"source":{"system":"sec-edgar","filing":"0001209191-22-002750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002750/doc4.xml","form_type":"4"}},{"id":2439235,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2022-01-10T23:24:45.000Z","date":"2022-01-06","kind":"exercise","acquired":true,"shares":1633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 365 shares of the Issuer's common stock acquired by the reporting person on May 15, 2021 and 405 shares acquired by the reporting person on November 15, 2021, pursuant to an employee stock purchase program."}],"balance_after":13774,"source":{"system":"sec-edgar","filing":"0001209191-22-002750","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919122002750/doc4.xml","form_type":"4"}},{"id":2734873,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-04-30T22:54:26.000Z","date":"2021-04-29","kind":"exercise","acquired":false,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":6010,"derivative":{"underlying":"Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001209191-21-029358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029358/doc4.xml","form_type":"4"}},{"id":2734872,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-04-30T22:54:26.000Z","date":"2021-04-30","kind":"sale","acquired":false,"shares":1054,"price":20.33,"value":21427.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":11371,"source":{"system":"sec-edgar","filing":"0001209191-21-029358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029358/doc4.xml","form_type":"4"}},{"id":2734871,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-04-30T22:54:26.000Z","date":"2021-04-29","kind":"exercise","acquired":true,"shares":3005,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The amount of securities beneficially owned reported in Column 5 above has been adjusted to correct an error in the Reporting Person's prior Form 4 caused by the failure to carry over the correct number of shares from the prior report. The number of shares owned prior to the transactions reported herein was 9,420 shares."}],"balance_after":12425,"source":{"system":"sec-edgar","filing":"0001209191-21-029358","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121029358/doc4.xml","form_type":"4"}},{"id":2833466,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-02-26T02:46:55.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":8855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning February 23 2022."}],"balance_after":8855,"derivative":{"underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001209191-21-014558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014558/doc4.xml","form_type":"4"}},{"id":2833465,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2021-02-26T02:46:55.000Z","date":"2021-02-23","kind":"grant","acquired":true,"shares":32608,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on February 23, 2022. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":32608,"derivative":{"exercise_price":49.74,"expiration_date":"2031-02-23","underlying":"Common Stock","underlying_shares":32608},"source":{"system":"sec-edgar","filing":"0001209191-21-014558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121014558/doc4.xml","form_type":"4"}},{"id":2875055,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:13.000Z","date":"2021-02-04","kind":"sale","acquired":false,"shares":2107,"price":50.61,"value":106635.27,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":9911,"source":{"system":"sec-edgar","filing":"0001209191-21-008658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008658/doc4.xml","form_type":"4"}},{"id":2875054,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-02-09T02:00:13.000Z","date":"2021-02-04","kind":"grant","acquired":true,"shares":6009,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On April 29, 2019, the reporting person was granted Restricted Stock Units (RSU's) that vest upon the Issuer's satisfaction of certain performance criteria. On February 4, 2021, the Issuer's Compensation Committee determined that certain performance criteria was achieved, resulting in the vesting of the RSU's as to the number of shares reported in column 4 of row 1 above."}],"balance_after":12018,"source":{"system":"sec-edgar","filing":"0001209191-21-008658","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121008658/doc4.xml","form_type":"4"}},{"id":2912682,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2021-01-09T00:30:26.000Z","date":"2021-01-06","kind":"exercise","acquired":false,"shares":1633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":4900,"derivative":{"underlying":"Common Stock","underlying_shares":1633},"source":{"system":"sec-edgar","filing":"0001209191-21-002834","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002834/doc4.xml","form_type":"4"}},{"id":2912681,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-01-09T00:30:26.000Z","date":"2021-01-06","kind":"sale","acquired":false,"shares":678,"price":53.34,"value":36164.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F3","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":5518,"source":{"system":"sec-edgar","filing":"0001209191-21-002834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002834/doc4.xml","form_type":"4"}},{"id":2912680,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2021-01-09T00:30:26.000Z","date":"2021-01-06","kind":"exercise","acquired":true,"shares":1633,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 712 shares of the Issuer's common stock acquired by the reporting person on November 13, 2020 pursuant to an employee stock purchase program."}],"balance_after":6196,"source":{"system":"sec-edgar","filing":"0001209191-21-002834","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919121002834/doc4.xml","form_type":"4"}},{"id":2998250,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-29T20:12:02.000Z","date":"2020-10-27","kind":"exercise","acquired":false,"shares":8750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"25% of the shares subject to the Stock Option vested and became exercisable on July 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":113750,"derivative":{"exercise_price":17.58,"expiration_date":"2028-07-17","underlying":"Common Stock","underlying_shares":8750},"source":{"system":"sec-edgar","filing":"0001209191-20-056219","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120056219/doc4.xml","form_type":"4"}},{"id":2998249,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-10-29T20:12:02.000Z","date":"2020-10-27","kind":"sale","acquired":false,"shares":8750,"price":45.1013,"value":394636.375,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/18/2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.525, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":3851,"source":{"system":"sec-edgar","filing":"0001209191-20-056219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120056219/doc4.xml","form_type":"4"}},{"id":2998248,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-10-29T20:12:02.000Z","date":"2020-10-27","kind":"exercise","acquired":true,"shares":8750,"price":17.58,"value":153825.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 1,410 shares of the Issuer's common stock acquired by the reporting person on May 15, 2020 pursuant to an employee stock purchase program."}],"balance_after":12601,"source":{"system":"sec-edgar","filing":"0001209191-20-056219","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120056219/doc4.xml","form_type":"4"}},{"id":3165656,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-05-01T22:00:19.000Z","date":"2020-04-29","kind":"exercise","acquired":false,"shares":3004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning 4/29/2020."}],"balance_after":9015,"derivative":{"underlying":"Common Stock","underlying_shares":3004},"source":{"system":"sec-edgar","filing":"0001209191-20-026619","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026619/doc4.xml","form_type":"4"}},{"id":3165655,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:19.000Z","date":"2020-04-30","kind":"sale","acquired":false,"shares":1072,"price":49.22,"value":52763.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units."}],"balance_after":2441,"source":{"system":"sec-edgar","filing":"0001209191-20-026619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026619/doc4.xml","form_type":"4"}},{"id":3165654,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2020-05-01T22:00:19.000Z","date":"2020-04-29","kind":"exercise","acquired":true,"shares":3004,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."}],"balance_after":3513,"source":{"system":"sec-edgar","filing":"0001209191-20-026619","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120026619/doc4.xml","form_type":"4"}},{"id":3315478,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2020-01-08T23:06:41.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":6533,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning January 6, 2021."}],"balance_after":6533,"derivative":{"underlying":"Common Stock","underlying_shares":6533},"source":{"system":"sec-edgar","filing":"0001209191-20-002600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002600/doc4.xml","form_type":"4"}},{"id":3315477,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2020-01-08T23:06:41.000Z","date":"2020-01-06","kind":"grant","acquired":true,"shares":23709,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on January 6, 2021. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":23709,"derivative":{"exercise_price":42.81,"expiration_date":"2030-01-06","underlying":"Common Stock","underlying_shares":23709},"source":{"system":"sec-edgar","filing":"0001209191-20-002600","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919120002600/doc4.xml","form_type":"4"}},{"id":3342529,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-12-13T22:34:51.000Z","date":"2019-12-11","kind":"exercise","acquired":false,"shares":17500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the 140,000 shares originally subject to the stock option vested and became exercisable on July 18, 2019. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":122500,"derivative":{"exercise_price":17.58,"expiration_date":"2028-07-17","underlying":"Common Stock","underlying_shares":17500},"source":{"system":"sec-edgar","filing":"0001209191-19-060475","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060475/doc4.xml","form_type":"4"}},{"id":3342528,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2019-12-13T22:34:51.000Z","date":"2019-12-11","kind":"sale","acquired":false,"shares":17500,"price":45.0615,"value":788576.25,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.00 to $45.215, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above."}],"balance_after":509,"source":{"system":"sec-edgar","filing":"0001209191-19-060475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060475/doc4.xml","form_type":"4"}},{"id":3342527,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Common Stock","published_at":"2019-12-13T22:34:51.000Z","date":"2019-12-11","kind":"exercise","acquired":true,"shares":17500,"price":17.58,"value":307650.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 452 shares of the Issuer's common stock acquired by the reporting person on May 15, 2019 and 57 shares of the Issuer's common stock acquired by the reporting person on November 15, 2019 pursuant to an employee stock purchase program."}],"balance_after":18009,"source":{"system":"sec-edgar","filing":"0001209191-19-060475","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119060475/doc4.xml","form_type":"4"}},{"id":3544597,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Restricted Stock Units","published_at":"2019-05-01T21:58:27.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":12019,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of ACADIA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in four equal annual installments beginning April 29, 2020."}],"balance_after":12019,"derivative":{"underlying":"Common Stock","underlying_shares":12019},"source":{"system":"sec-edgar","filing":"0001209191-19-026845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026845/doc4.xml","form_type":"4"}},{"id":3544596,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP & General Counsel"}}],"security":"Stock Options (Right to Buy)","published_at":"2019-05-01T21:58:27.000Z","date":"2019-04-29","kind":"grant","acquired":true,"shares":42173,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option will vest and become exercisable on April 29, 2020. The remaining shares vest and become exercisable in 36 equal monthly installments thereafter."}],"balance_after":42173,"derivative":{"exercise_price":25.12,"expiration_date":"2029-04-29","underlying":"Common Stock","underlying_shares":42173},"source":{"system":"sec-edgar","filing":"0001209191-19-026845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000120919119026845/doc4.xml","form_type":"4"}},{"id":3863816,"issuer":{"id":3913,"kind":"organization","name":"ACADIA PHARMACEUTICALS INC"},"owners":[{"id":95346,"kind":"person","name":"KIM AUSTIN D.","position":1,"cik":"0001746240","reported_name":"KIM AUSTIN D.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP AND GENERAL COUNSEL"}}],"security":"Stock Option (right to buy)","published_at":"2018-07-20T23:02:18.000Z","date":"2018-07-18","kind":"grant","acquired":true,"shares":140000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the Stock Option vest and become exercisable on July 18, 2019.  The remaining shares vest and become exercisable thereafter in 36 equal monthly installments."}],"balance_after":140000,"derivative":{"exercise_price":17.58,"expiration_date":"2028-07-17","underlying":"Common Stock","underlying_shares":140000},"source":{"system":"sec-edgar","filing":"0001415889-18-001160","document":"form4-07202018_040702.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1070494/000141588918001160/form4-07202018_040702.xml","form_type":"4"}}]}